Analyst firms · Wells Fargo · GKOS

Wells Fargo GKOS price target and rating history

Glaukos Corporation (GKOS) · Health Care

Wells Fargo rates Glaukos Corporation (GKOS) Overweight with a $120 price target, as of its latest action on Oct 27, 2025. It has published 5 rating actions on GKOS since July 2021, including 3 upgrades and 2 downgrades.

Current rating
Overweight
Price target
$120
Median target, all firms
Too few
Actions on GKOS
5

Wells Fargo price target on GKOS

$120$81$4120222023202420252026
Wells Fargo price target on GKOS, each point a stated target, July 2021 to October 2025.

Every Wells Fargo rating on GKOS

How other firms rate GKOS

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
UBSNeutralJul 28, 2026
H.C. WainwrightBuy$168Jul 6, 2026

Questions about Wells Fargo and GKOS

What is Wells Fargo's price target for GKOS?
Wells Fargo's latest stated price target for Glaukos Corporation (GKOS) is $120, from its action on Oct 27, 2025.
What is Wells Fargo's rating on GKOS?
Wells Fargo rates GKOS Overweight, a bullish rating, as of Oct 27, 2025.
When did Wells Fargo last change its view on GKOS?
On Oct 27, 2025, Wells Fargo upgrades to Overweight from Equal Weight, price target $120.

More GKOS rating histories

All Wells Fargo ratingsGKOS news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.